Trials / Recruiting
RecruitingNCT06899529
Immediate Postoperative Bevacizumab Administration in Proliferative Diabetic Retinopathy Patients Undergoing Vitrectomy
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 150 (estimated)
- Sponsor
- Christian Ophthalmic Surgery Expedition Network · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Patients undergoing surgery for complications related to diabetes will be recruited.
Detailed description
Proliferative Diabetic Retinopathy patients undergoing pars plana vitrectomy will be randomized whether or not to receive intravitreal bevacizumab at the conclusion of the operation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Bevacizumab | Bevacizumab will be given immediately after surgery in the Treatment Group |
Timeline
- Start date
- 2025-03-20
- Primary completion
- 2027-03-20
- Completion
- 2027-05-20
- First posted
- 2025-03-28
- Last updated
- 2025-03-28
Locations
1 site across 1 country: Mexico
Source: ClinicalTrials.gov record NCT06899529. Inclusion in this directory is not an endorsement.